Clinical Trials on Immune Checkpoints Inhibitors in New Zealand
Total 8388 results
-
Lutris Pharma Ltd.CompletedEGFR Inhibitor Induced Acneiform LesionsUnited States, Israel
-
Hoffmann-La RocheCompletedRheumatoid ArthritisCanada, New Zealand, Spain
-
CSL BehringCompletedEmphysema | Alpha 1-proteinase Inhibitor DeficiencyAustralia, Canada, Czech Republic, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden
-
Trans Tasman Radiation Oncology GroupAustralasian Leukaemia and Lymphoma Group; Australasian Radiation Oncology... and other collaboratorsCompleted
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisGermany, New Zealand, Australia
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic... and other conditionsUnited States, Canada, New Zealand
-
University Hospital, EssenCompletedRight-Sided Heart Failure | Phosphodiesterase Inhibitor Adverse ReactionGermany
-
Trans Tasman Radiation Oncology GroupAustralasian Leukaemia and Lymphoma GroupCompletedPrimary Central Nervous System LymphomaAustralia, New Zealand
-
Omeros CorporationRecruitingC3 Glomerulopathy | Idiopathic Immune Complex-Mediated GlomerulonephritisLithuania, New Zealand, Poland, Tunisia, Turkey, United Kingdom
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsTaiwan, United Kingdom, Thailand, Serbia, Croatia, Italy, Poland, Romania, Hungary, Malaysia, United States, Austria, Brazil, Greece, Japan, Puerto Rico, Russian Federation, South Africa, Turkey
-
GlaxoSmithKlineCompletedArthritis, RheumatoidUkraine, Russian Federation, New Zealand, Australia, Serbia
-
Mundipharma Research LimitedCompletedAsthmaUnited Kingdom, Sweden, Australia, New Zealand, Slovakia
-
Hoffmann-La RocheCompletedRheumatoid ArthritisUnited States, New Zealand
-
AllerganCompletedAtopic ConjunctivitisCanada, Czech Republic, United States, Italy, Israel, New Zealand, Spain, India, Germany, Australia, France, United Kingdom
-
Grifols Therapeutics LLCTerminatedType 1 Diabetes MellitusUnited States
-
GlaxoSmithKlineCompletedArthritis, RheumatoidRussian Federation, Australia, Belgium, Spain, United States, New Zealand, Italy, Poland, France
-
TakedaTakeda Development Center Americas, Inc.CompletedAngioedemaUnited States, Spain, Netherlands, Hungary, Italy, Canada, Germany, France, Japan, Poland
-
Hoffmann-La RocheTerminatedLymphoma, Large B-Cell, Diffuse | Follicular LymphomaUnited States, Australia, Germany, Korea, Republic of, New Zealand
-
Kadmon, a Sanofi CompanyCompletedImmune System Disorder (Healthy Volunteer)United States
-
Kadmon, a Sanofi CompanyCompletedImmune System Disorder (Healthy Volunteer)United States
-
Trans Tasman Radiation Oncology GroupAustralasian Leukaemia and Lymphoma GroupCompletedFollicular LymphomaAustralia, New Zealand, Canada
-
Checkpoint Therapeutics, Inc.CompletedLung Diseases | Adenocarcinoma | Carcinoma, Non-Small-Cell Lung | Lung NeoplasmsUnited States, Thailand, New Zealand, Australia, Poland
-
Olivia Newton-John Cancer Research InstituteBristol-Myers SquibbActive, not recruitingNeuroendocrine Tumors | Advanced Biliary Tract Cancer | Female Reproductive System Neoplasm | MSI-H Solid Malignant TumorNew Zealand, Australia
-
Novo Nordisk A/SRecruitingHaemophilia A With Inhibitors | Haemophilia AUnited States, Korea, Republic of, France, Spain, Romania, Canada, Taiwan, China, Lithuania, Netherlands, India, South Africa, Russian Federation, Austria, Belgium, Czechia, Denmark, Germany, Ireland, Italy, Japan, Latvia, Malaysia, M... and more
-
Novo Nordisk A/SRecruitingHaemophilia A and B With and Without InhibitorsUnited States, Spain, Italy, Estonia, Thailand, Canada, India, Malaysia, United Kingdom, Turkey, South Africa, Lebanon, Bosnia and Herzegovina, Bulgaria, France, Greece, Japan, Lithuania, Norway, Poland, Romania, Russian Federation, Swede... and more
-
University of New MexicoRecruitingDNA Damage | Immune System DisorderUnited States
-
Eisai Inc.CompletedImmune Thrombocytopenia | Chronic ThrombocytopeniaPoland, Ukraine, Belgium, Bulgaria, South Africa, Netherlands, New Zealand, Singapore, Australia, Slovakia, Czechia
-
Society for Applied StudiesNorwegian Institute of Public Health; Christian Medical College, Vellore, IndiaCompletedInnate Immune ResponseIndia
-
Rochester General HospitalCompletedSecondary Immune DeficiencyUnited States
-
GB005, Inc., a wholly owned subsidiary of Gossamer...TerminatedCNS LymphomaUnited States, Canada, Israel, Australia, New Zealand, France
-
Medeor Therapeutics, Inc.RecruitingImmune ToleranceUnited States
-
Margrethe Langer BroUniversity of Aarhus; Danish Cancer SocietyCompletedNon Hodgkin´s Lymphomas | Hodgkin´s LymphomasDenmark
-
Columbia UniversityNational Institute of Mental Health (NIMH)CompletedHIV | Patient ComplianceUnited States
-
Rutgers, The State University of New JerseyCompletedImmune SystemUnited States
-
Arrowhead PharmaceuticalsRecruitingIgA Nephropathy | C3 GlomerulopathyNew Zealand, Australia, Korea, Republic of, Thailand, Germany, United Kingdom, Georgia
-
Memorial Sloan Kettering Cancer CenterSobi, Inc.RecruitingImmune System Diseases | Autoimmune Lymphoproliferative | Primary Immune Regulatory DisorderUnited States
-
ApcinteX LtdCentessa Pharmaceuticals plcRecruitingHemophilia B | Hemophilia B With InhibitorUnited States, Spain, Australia, Taiwan, France, Armenia, Germany
-
Boehringer IngelheimCompletedHealthy | Arthritis, RheumatoidGermany, Netherlands, New Zealand, Poland, Spain, Czechia
-
Baxalta now part of ShireTerminatedSystemic Lupus ErythematosusAustralia, United States, New Zealand, Mexico, Canada
-
William PomatThe University of Western AustraliaCompleted
-
University of SydneyNational Health and Medical Research Council, Australia; Mylan Pharmaceuticals... and other collaboratorsRecruitingDiabetic Retinopathy | Diabetic Nephropathies | Type 1 Diabetes MellitusAustralia, Hong Kong, New Zealand
-
Rochester General HospitalCompletedSecondary Immune Deficiency DisorderUnited States
-
Rockefeller UniversityCompleted
-
Akesobio Australia Pty LtdRecruitingPhase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic DermatitisAtopic DermatitisUnited States, Australia, New Zealand
-
Western Sydney Local Health DistrictRecruitingKidney Transplant Rejection | Immune ToleranceAustralia
-
Lymphoma Study AssociationInstitute of Cancer Research, United Kingdom; Australasian Leukaemia and Lymphoma... and other collaboratorsCompletedFollicular LymphomaFrance, Thailand, Belgium, Spain, Argentina, Australia, Brazil, Colombia, Denmark, Netherlands, New Zealand, Peru
-
Northwell HealthNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedImmune System DiseasesUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedGraft Versus Host DiseaseUnited States
-
St. Luke's-Roosevelt Hospital CenterGilead SciencesCompleted
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedGraft Versus Host DiseaseUnited States